These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
304 related items for PubMed ID: 31814031
21. Strongyloidiasis and infective dermatitis alter human T lymphotropic virus-1 clonality in vivo. Gillet NA, Cook L, Laydon DJ, Hlela C, Verdonck K, Alvarez C, Gotuzzo E, Clark D, Farré L, Bittencourt A, Asquith B, Taylor GP, Bangham CR. PLoS Pathog; 2013; 9(4):e1003263. PubMed ID: 23592987 [Abstract] [Full Text] [Related]
23. Atypical clinical presentation of strongyloidiasis in a patient co-infected with human T cell lymphotrophic virus type I. Porto MA, Alcântara LM, Leal M, Castro N, Carvalho EM. Am J Trop Med Hyg; 2005 Feb; 72(2):124-5. PubMed ID: 15741545 [Abstract] [Full Text] [Related]
24. Strongyloides hyperinfection following hematopoietic stem cell transplant in a patient with HTLV-1-associated T-cell leukemia. Alpern JD, Arbefeville SS, Vercellotti G, Ferrieri P, Green JS. Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27860061 [Abstract] [Full Text] [Related]
25. Multiorgan Dysfunction Syndrome from Strongyloides stercoralis Hyperinfection in a Patient with Human T-Cell Lymphotropic Virus-1 Coinfection After Initiation of Ivermectin Treatment. Choksi TT, Madison G, Dar T, Asif M, Fleming K, Clarke L, Danilewitz M, Hennawy R. Am J Trop Med Hyg; 2016 Oct 05; 95(4):864-867. PubMed ID: 27527631 [Abstract] [Full Text] [Related]
26. Regulatory T cell expansion in HTLV-1 and strongyloidiasis co-infection is associated with reduced IL-5 responses to Strongyloides stercoralis antigen. Montes M, Sanchez C, Verdonck K, Lake JE, Gonzalez E, Lopez G, Terashima A, Nolan T, Lewis DE, Gotuzzo E, White AC. PLoS Negl Trop Dis; 2009 Jun 09; 3(6):e456. PubMed ID: 19513105 [Abstract] [Full Text] [Related]
27. [Parasitic pneumonia and HTLV-1 infection]. Cadelis G, Ehret N, Da Cunha S, Dranebois S, Saillard E. Rev Mal Respir; 2014 Nov 09; 31(9):867-70. PubMed ID: 25433594 [No Abstract] [Full Text] [Related]
28. Seroepidemiology of Strongyloides stercoralis in Dhaka, Bangladesh. Sultana Y, Gilbert GL, Ahmed BN, Lee R. Parasitology; 2012 Sep 09; 139(11):1513-20. PubMed ID: 22813776 [Abstract] [Full Text] [Related]
29. [Duodenal Linphoma asociated to Strongyloides stercoralis infection. Two types of HTLV-1 infection]. Guevara Miranda J, Guzmán Rojas P, Espinoza-Ríos J, Mejía Cordero F. Rev Gastroenterol Peru; 2017 Sep 09; 37(2):169-172. PubMed ID: 28731999 [Abstract] [Full Text] [Related]
30. Predictive markers for development of strongyloidiasis in patients infected with both Strongyloides stercoralis and HTLV-1. Satoh M, Kiyuna S, Shiroma Y, Toma H, Kokaze A, Sato Y. Clin Exp Immunol; 2003 Sep 09; 133(3):391-6. PubMed ID: 12930366 [Abstract] [Full Text] [Related]
31. [A not so rare co-infection]. Pinard C, Jean-Etienne A, Dufrenot Petit Jean Roget L, Bapte J, Ortonne N, Fardin AA, Molinié V. Ann Pathol; 2016 Oct 09; 36(5):358-361. PubMed ID: 27641818 [No Abstract] [Full Text] [Related]
32. Severe intestinal obstruction due to Strongyloides stercoralis in a pregnant woman. Malézieux-Picard A, Saint-Paul MC, Dellamonica J, Courjon J, Tieulié N, Marty P, Fuzibet JG, Collomp R, Marinho JA, Queyrel V. Med Mal Infect; 2017 Oct 09; 47(6):429-431. PubMed ID: 28651833 [No Abstract] [Full Text] [Related]
33. [Clinical and immunological consequences of the association between HTLV-1 and strongyloidiasis]. Porto MA, Muniz A, Oliveira Júnior J, Carvalho EM. Rev Soc Bras Med Trop; 2002 Oct 09; 35(6):641-9. PubMed ID: 12612748 [Abstract] [Full Text] [Related]
34. Reduced efficacy of treatment of strongyloidiasis in HTLV-I carriers related to enhanced expression of IFN-gamma and TGF-beta1. Satoh M, Toma H, Sato Y, Takara M, Shiroma Y, Kiyuna S, Hirayama K. Clin Exp Immunol; 2002 Feb 09; 127(2):354-9. PubMed ID: 11876761 [Abstract] [Full Text] [Related]
35. Endoscopic and histopathological study on the duodenum of Strongyloides stercoralis hyperinfection. Kishimoto K, Hokama A, Hirata T, Ihama Y, Nakamoto M, Kinjo N, Kinjo F, Fujita J. World J Gastroenterol; 2008 Mar 21; 14(11):1768-73. PubMed ID: 18350608 [Abstract] [Full Text] [Related]
36. Normal serum IgE levels and eosinophil counts exhibited during Strongyloides stercoralis infection. Higashiarakawa M, Hirata T, Tanaka T, Parrott G, Kinjo T, Naka H, Hokama A, Fujita J. Parasitol Int; 2017 Feb 21; 66(1):807-812. PubMed ID: 27744050 [Abstract] [Full Text] [Related]
37. Strongyloides stercoralis: a cause of morbidity and mortality for indigenous people in Central Australia. Einsiedel L, Fernandes L. Intern Med J; 2008 Sep 21; 38(9):697-703. PubMed ID: 19143887 [Abstract] [Full Text] [Related]
38. Cutaneous manifestation of disseminated strongyloidiasis in a patient coinfected with HTLV-I. Arch EL, Schaefer JT, Dahiya A. Dermatol Online J; 2008 Dec 15; 14(12):6. PubMed ID: 19265619 [Abstract] [Full Text] [Related]
39. Impairment of host immune response against strongyloides stercoralis by human T cell lymphotropic virus type 1 infection. Hirata T, Uchima N, Kishimoto K, Zaha O, Kinjo N, Hokama A, Sakugawa H, Kinjo F, Fujita J. Am J Trop Med Hyg; 2006 Feb 15; 74(2):246-9. PubMed ID: 16474078 [Abstract] [Full Text] [Related]
40. [Strongyloides stercoralis hyperinfection syndrome in a patient with Behçet's Disease]. Yılmaz I, Cağlar B, Akay BN, Alkız G, Boyvat A, Akyol A. Turkiye Parazitol Derg; 2013 Feb 15; 37(2):139-42. PubMed ID: 23955913 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]